FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Diabeloop Receives CE Mark for Blood Sugar Monitoring Technology

Nov. 15, 2018
A A

Diabeloop’s DBLG1 technology for monitoring and maintaining blood sugar levels has earned the CE Mark.

The self-learning, customizable system can mimic the pancreas’ insulin-dispensing functions and adapt to the patient.

The DBLG1 links to a continuous blood glucose monitoring system and an insulin patch pump to predict glucose levels and optimally control the pump.

View today's stories